- Cancer cells killed with their own carbon monoxide
- AstraZeneca and Oracle launch global AI collaboration to advance clinical trial optimisation and support better patient outcomes
- Can we stop antibiotic resistance in ruining promising drugs before they reach patients?
- New therapeutic approach for the brain disorder SCA3
- FDA launches new program to advance neuroscience medical product development
- Drug substance reduces blood vessel malformations in the brain
- Creating 'satellite maps' of proteins could transform drug therapies
- New AI platform helps uncover promising cancer drug combinations
- AI aids in the development of new active ingredients
- Transparent minispheres reveal that some look-alike cancer drugs part ways in 3D
Stay updated on the Breaking News!
Cancer cells killed with their own carbon monoxide
- Details
- Category: Research
AstraZeneca and Oracle launch global AI collaboration to advance clinical trial optimisation and support better patient outcomes
- Details
- Category: AstraZeneca
AstraZeneca and Oracle Health and Life Sciences announced a unique collaboration to leverage AstraZeneca's scientific, clinical development and regulatory expertise with Oracle's real-world data, cloud infrastructure, and AI-enabled clinical capabilities to accelerate clinical research and bring evidence-driven insights into care workflows to accelerate clinical trial optimisation and help more patients receive the right care sooner.
Can we stop antibiotic resistance in ruining promising drugs before they reach patients?
- Details
- Category: Research
New therapeutic approach for the brain disorder SCA3
- Details
- Category: Research
FDA launches new program to advance neuroscience medical product development
- Details
- Category: FDA
The U.S. Food and Drug Administration announced the launch of the Neuroscience Advancement and Innovation Nexus (NAIN), a new agency program aligned with the Trump Administration’s efforts to accelerate medical innovation and deliver breakthrough treatments. NAIN is designed to advance the science, tools, and regulatory approaches needed to support the development of medical products for conditions affecting the brain and nervous system.
Drug substance reduces blood vessel malformations in the brain
- Details
- Category: Research
Creating 'satellite maps' of proteins could transform drug therapies
- Details
- Category: Research
A University at Buffalo researcher has developed this novel technology, called hexagonal micro-scaffold assisted spatial proteomics (hex-MASP), which has the potential to transform how researchers study and create new drugs.
New AI platform helps uncover promising cancer drug combinations
- Details
- Category: Research
The platform, called MAESTRO and described in Advanced Science, uses large language models, or LLMs, to analyze scientific knowledge about how drugs work and the biological pathways cancer cells use to survive treatment.
AI aids in the development of new active ingredients
- Details
- Category: Research
Transparent minispheres reveal that some look-alike cancer drugs part ways in 3D
- Details
- Category: Research